Pacira BioSciences Inc PCRX

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

CEO

Mr. Frank D. Lee

Founded

2006

Employees

711

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Tampa, FL USA

High Today

$25.08

Low Today

$24.33

Open Today

$24.47

Volume Today

450,100.0

52 Week High

$31.67

52 Week Low

$11.16

Average Volume

992,604